Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

Z Chen, F Han, Y Du, H Shi, W Zhou - Signal transduction and targeted …, 2023 - nature.com
Having a hypoxic microenvironment is a common and salient feature of most solid tumors.
Hypoxia has a profound effect on the biological behavior and malignant phenotype of …

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Z Luo, M Tian, G Yang, Q Tan, Y Chen, G Li… - Signal transduction and …, 2022 - nature.com
Molecular oxygen (O2) is essential for most biological reactions in mammalian cells. When
the intracellular oxygen content decreases, it is called hypoxia. The process of hypoxia is …

Hypoxia as a driver of resistance to immunotherapy

J Kopecka, IC Salaroglio, E Perez-Ruiz… - Drug Resistance …, 2021 - Elsevier
Hypoxia, a hallmark of solid tumors, determines the selection of invasive and aggressive
malignant clones displaying resistance to radiotherapy, conventional chemotherapy or …

Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial

WD Tap, AJ Wagner, P Schöffski, J Martin-Broto… - Jama, 2020 - jamanetwork.com
Importance Patients with advanced soft tissue sarcoma (STS) have a median overall survival
of less than 2 years. In a phase 2 study, an overall survival benefit in this population was …

[HTML][HTML] Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

J Martin-Broto, N Hindi, G Grignani… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Sarcomas exhibit low expression of factors related to immune response, which
could explain the modest activity of PD-1 inhibitors. A potential strategy to convert a cold into …

A comprehensive review on solitary fibrous tumor: new insights for new horizons

J Martin-Broto, JL Mondaza-Hernandez, DS Moura… - Cancers, 2021 - mdpi.com
Simple Summary Solitary fibrous tumor (SFT) is a malignant condition that exhibits different
clinical behaviors ranging from low to high aggressive SFT, with dedifferentiated SFT (DD …

Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a …

P Pautier, A Italiano, S Piperno-Neumann… - The Lancet …, 2022 - thelancet.com
Background Metastatic leiomyosarcomas have a poor prognosis, and currently doxorubicin
alone is used as the standard first-line treatment. Doxorubicin combined with trabectedin …

Improving immunotherapy efficacy in soft-tissue sarcomas: A biomarker driven and histotype tailored review

M Roulleaux Dugage, EF Nassif, A Italiano… - Frontiers in …, 2021 - frontiersin.org
Anti-PD-(L) 1 therapies yield a disappointing response rate of 15% across soft-tissue
sarcomas, even if some subtypes benefit more than others. The proportions of TAMs and …

Uterine leiomyosarcoma: A review of the literature and update on management options

ME Roberts, JT Aynardi, CS Chu - Gynecologic Oncology, 2018 - Elsevier
Uterine leiomyosarcoma is the most common type of uterine sarcoma. It is an extremely
aggressive malignancy associated with a poor overall prognosis. Women affected may vary …

Clickable polysaccharides for biomedical applications: a comprehensive review

MK Yazdi, SM Sajadi, F Seidi, N Rabiee… - Progress in polymer …, 2022 - Elsevier
Recent advances in materials science and engineering highlight the importance of
designing sophisticated biomaterials with well-defined architectures and tunable properties …